Astera Labs (ALAB) Projected to Post Earnings on Tuesday

Astera Labs (NASDAQ:ALAB) is anticipated to issue its Q2 2025 quarterly earnings data after the market closes on Tuesday, August 5th. Analysts expect the company to announce earnings of $0.33 per share and revenue of $172.46 million for the quarter. Astera Labs has set its Q2 2025 guidance at 0.320-0.330 EPS.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.05. Astera Labs had a net margin of 8.44% and a return on equity of 2.57%. The business had revenue of $159.44 million during the quarter, compared to the consensus estimate of $151.55 million. During the same quarter in the previous year, the firm posted $0.10 EPS. The firm’s revenue was up 144.1% on a year-over-year basis. On average, analysts expect Astera Labs to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Astera Labs Trading Up 1.5%

NASDAQ:ALAB opened at $124.05 on Tuesday. Astera Labs has a 12 month low of $36.22 and a 12 month high of $147.39. The company has a market cap of $20.46 billion, a PE ratio of 563.89, a price-to-earnings-growth ratio of 5.74 and a beta of 1.18. The company has a 50 day simple moving average of $96.70 and a two-hundred day simple moving average of $85.75.

Insider Activity

In other news, COO Sanjay Gajendra sold 165,000 shares of Astera Labs stock in a transaction dated Wednesday, July 9th. The shares were sold at an average price of $98.61, for a total value of $16,270,650.00. Following the sale, the chief operating officer owned 695,000 shares in the company, valued at $68,533,950. This trade represents a 19.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Jitendra Mohan sold 76,258 shares of Astera Labs stock in a transaction dated Monday, July 21st. The shares were sold at an average price of $112.72, for a total transaction of $8,595,801.76. Following the completion of the sale, the chief executive officer owned 475,421 shares in the company, valued at approximately $53,589,455.12. This trade represents a 13.82% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 2,181,759 shares of company stock worth $200,883,431 in the last ninety days.

Hedge Funds Weigh In On Astera Labs

Several hedge funds and other institutional investors have recently modified their holdings of the business. Empowered Funds LLC raised its stake in Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after purchasing an additional 4,183 shares during the period. AQR Capital Management LLC raised its stake in Astera Labs by 213.4% during the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after purchasing an additional 7,756 shares during the period. Finally, Royal Bank of Canada raised its stake in Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on ALAB shares. Wall Street Zen downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. Needham & Company LLC cut their price objective on shares of Astera Labs from $140.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, May 7th. Morgan Stanley upgraded shares of Astera Labs from an “equal weight” rating to an “overweight” rating and set a $99.00 target price on the stock in a research note on Monday, May 12th. Evercore ISI lifted their target price on shares of Astera Labs from $87.00 to $104.00 and gave the company an “outperform” rating in a research note on Wednesday, May 21st. Finally, William Blair began coverage on shares of Astera Labs in a research note on Thursday, May 22nd. They set an “outperform” rating on the stock. Four analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $102.67.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.